Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Thyrocare Technologies Ltd. Share Price
Day's Range
Day's Range
Low
₹583.00
High
₹599.00
Price Summary
| Previous Close | ₹596.05 |
|---|---|
| Day's Range | ₹583.00 - ₹599.00 |
| Open | ₹586.00 |
| 52 Week Range | ₹342.55 - ₹662.00 |
| Volume | 2,76,112 |
| Market Cap | ₹0.01 |
| Previous Close | ₹598.20 |
|---|---|
| Day's Range | ₹580.65 - ₹599.00 |
| Open | ₹580.65 |
| 52 Week Range | ₹342.55 - ₹662.00 |
| Volume | 38,367 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1,645.77 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 2.40 |
| Price/Earning (TTM) | 52.74 |
| TTM EPS (₹) | 11.08 |
| P/E Ratio | 34.07 |
| Book Value(₹) | 14.77 |
| PAT Margin (%) | 19.64 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 38.30 |
| Trade Value ( ₹ in Lacs) | 229.51 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 2.40 |
| Price/Earning (TTM) | 52.74 |
| TTM EPS (₹) | 11.08 |
| P/E Ratio | 34.07 |
| Book Value(₹) | 14.77 |
| PAT Margin (%) | 19.64 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 38.30 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1930.3 | 6331.0 |
| Expenses | N/A | N/A |
| PBT | 504.8 | 1512.1 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 382.9 | 957.8 |
About Thyrocare Technologies Ltd.
| Founded | 2000 |
|---|---|
| Managing Director | Rahul Guha |
| NSE Symbol | THYROCARE |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,58,248.99 | 1,917.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,25,648.29 | 8,680.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,84,891.11 | 4,920.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,25,092.65 | 8,878.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,926.93 | 1,420.00 | 1,165.70 - 1,165.70 |
| Lenskart Solutions Ltd. | 1,14,742.03 | 657.00 | 0.00 - 0.00 |
| Zydus Lifesciences Ltd. | 1,09,825.17 | 1,130.00 | 835.50 - 835.50 |
| Lupin Ltd. | 1,00,134.44 | 2,175.00 | 1,875.00 - 1,875.00 |
| Dr. Reddy's Laboratories Ltd. | 99,702.02 | 1,191.00 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 98,086.54 | 2,367.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Thyrocare Technologies informs about disclosures
Thyrocare Technologies informs about SAST
Thyrocare Technologies informs about disclosure
Thyrocare Technologies informs about disclosure
Broach Lifecare Hospital informs about resignation of CFO
Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Broach Lifecare Hospital has informed that Company has received resignation letter dated 24th August, 2026, from URVI MRUNAL HINDIA from the position of Chief Financial Officer (CFO) with effect from closure of business hours 31st August, 2026 and the same is acknowledged by the Company today, on 25th August, 2026. Further, the disclosure of information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular- SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30 January 2026 are attached as Annexure-I.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Thyrocare Technologies Ltd. is ₹596.05 as of 2026-08-25.
The market capitalisation of Thyrocare Technologies Ltd. is ₹9,298.44 as of 2026-08-24.
The 1-year return of Thyrocare Technologies Ltd. is 172.15% as of 2026-08-25.
The P/E ratio of Thyrocare Technologies Ltd. is 34.07 as of 2026-08-25.
The 52-week high and low of Thyrocare Technologies Ltd. are ₹662.00 and ₹342.55, respectively, as of 2026-08-25.
People Also Ask
As of recent public disclosures, Thyrocare Technologies Ltd’s leadership team oversees diagnostics operations, laboratory services, preventive healthcare, and strategic business initiatives across its network.
Thyrocare Technologies Ltd competes with diagnostic laboratory chains, pathology service providers, healthcare testing companies, and preventive healthcare businesses operating across India.
Thyrocare Technologies Ltd became part of the API Holdings group following a majority stake acquisition through the parent company associated with the PharmEasy platform.
Thyrocare Technologies Ltd provides diagnostic testing, preventive healthcare services, pathology solutions, radiology services, and laboratory testing facilities across India.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
